#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile idiopathic arthritis Red blood cell abnormality Cryoglobulinaemia Intracranial germ cell tumour Medulloblastoma recurrent Microvillous inclusion disease Trigeminal neuralgia Anal cancer recurrent Pulmonary hypertension Arterial tortuosity syndrome Congenital hypotransferrinaemia Acute myeloid leukaemia (in remission) Tuberous sclerosis complex Duchenne muscular dystrophy Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome – Basic Information Medulloblastoma Alexander disease – Treatment Prader-Willi syndrome Mucopolysaccharidosis II – Life with Disease Acquired haemophilia – Diagnostics Angiosarcoma recurrent – Diagnostics Idiopathic pulmonary fibrosis – Diagnostics Mantle cell lymphoma refractory – Trials in Disease IgA nephropathy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SIGVOTATUG VEDOTIN PETHIDINE HYDROCHLORIDE Rbl012.2 Relatlimab Enpatoran Zimberelimab GSKVX000000017986 Ambrisentan Sodium Dazodalibep Ziclumeran ANGIOTENSIN II Izokibep Clemastine Lebrikizumab Dostarlimab Threonine Bempedoic Acid Carcik-Cd19 Cells Wt1 Lamp Mrna Dc More therapies…

    Learn about Your Condition

    Dent's disease Atrial flutter Diverticulitis Major depression Urethral stenosis Burkitt's lymphoma Myocarditis Metastases to meninges Apheresis Urticaria chronic Constipation Cerebrovascular accident Lung adenocarcinoma Laryngeal cancer Cerebral amyloid angiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pancreatic carcinoma metastatic

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Study Comparing Irinotecan, Fluorouracil, Folinic Acid, and Drug Combination for Patients with Metastatic Pancreatic Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Irinotecan
    • Fluorouracil
    • Folinic Acid
    France

  • Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Fluorouracil
    • Gemcitabine
    • Irinotecan Hydrochloride Trihydrate
    The Netherlands

  • Study on Valproic Acid, Simvastatin, and Gemcitabine for Untreated Metastatic Pancreatic Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Simvastatin
    • Valproic Acid
    • Capecitabine
    Italy Spain

  • Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Calcium Folinate
    • Irinotecan
    • Fluorouracil
    Austria Belgium Denmark Finland France Germany +6

  • Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma recurrent
    • Pancreatic carcinoma metastatic
    • Pancreatic carcinoma
    Investigated Drugs:
    • Dabrafenib
    • Erlotinib
    • Pemigatinib
    Denmark
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!